1 - 25 of 45 results for author:"Lu Z.-H." in Literature citations
Results Customize
› Repeat search in UniProtKB (35)
| Different effects of ERbeta and TROP2 expression in Chinese patients with early-stage colon cancer. Fang Y.J., Wang G.Q., Lu Z.H., Zhang L., Li J.B., Wu X.J., Ding P.R., Ou Q.J., Zhang M.F., Jiang W. et al. Tumour Biol. 33:2227-2235(2012) · Mapped (3) |
| Impact of ERbeta and CD44 expression on the prognosis of patients with stage II colon cancer. Fang Y.J., Zhang L., Wu X.J., Lu Z.H., Li J.B., Ou Q.J., Zhang M.F., Ding P.R., Pan Z.Z., Wan D.S. Tumour Biol. 33:1907-1914(2012) · Mapped (6) |
| CD25 is a novel marker of hepatic bile canaliculus. Lu Z.H., -Chen W., Ju C.X., -Den J., Kuai S.G., Pei H., Huang L.H., Gu X.B., Ying Y.X., Hu X.Q. et al. Int. J. Surg. Pathol. 20:455-461(2012) · Mapped (6) |
| Polymorphisms of dihydropyrimidine dehydrogenase gene and clinical outcomes of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population. Zhang X.P., Bai Z.B., Chen B.A., Feng J.F., Yan F., Jiang Z., Zhong Y.J., Wu J.Z., Chen L., Lu Z.H. et al. Chin. Med. J. 125:741-746(2012) · Mapped (2) |
| [Expression of matrix metalloproteinase 1 in tissue of colon carcinoma and its clinical prognostic significance]. Lu Z.H., Fang Y.J., Wu X.J., Pan Z.Z., Wan D.S. Zhonghua Yi Xue Za Zhi 91:2895-2898(2011) · Mapped (11) |
| XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer. Zhu X.L., Sun X.C., Chen B.A., Sun N., Cheng H.Y., Li F., Zhang H.M., Feng J.F., Qin S.K., Cheng L. et al. Chin. Med. J. 123:3427-3432(2010) · Mapped (12) |
| Fascin promotes the motility and invasiveness of pancreatic cancer cells. Xu Y.F., Yu S.N., Lu Z.H., Liu J.P., Chen J. World J. Gastroenterol. 17:4470-4478(2011) · Mapped (4) |
| [LRP16 gene causes insulin resistance in C2-C12 cells by inhibiting the IRS-1 signaling and the transcriptional activity of peroxisome proliferator actived receptor gamma]. Zang L., Mu Y.M., Lu Z.H., Xue B., Ma X.L., Yang G.Q., Ba J.M., Dou J.T., Lu J.M. Zhonghua Yi Xue Za Zhi 91:1408-1412(2011) · Mapped (14) |
| Expression of COX-2, MMP-2 and VEGF in stage II and III colorectal cancer and the clinical significance. Peng Z.H., Wan D.S., Li L.R., Chen G., Lu Z.H., Wu X.J., Kong L.H., Pan Z.Z. Hepatogastroenterology 58:369-376(2011) · Mapped (13) |
| [Significance of chemokine receptor CXCR3 expression in breast cancer]. Li L., Chen J., Lu Z.H., Yu S.N., Luo Y.F., Zhao W.G., Ma Y.H., Jia C.W. Zhonghua Bing Li Xue Za Zhi 40:85-88(2011) · Mapped (1) |
| Strain-specific copy number variation in the intelectin locus on the 129 mouse chromosome 1. Lu Z.H., di Domenico A., Wright S.H., Knight P.A., Whitelaw C.B., Pemberton A.D. BMC Genomics 12:110-110(2011) · UniProtKB (11) · Mapped (24) |
| Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice. Kladney R.D., Cardiff R.D., Kwiatkowski D.J., Chiang G.G., Weber J.D., Arbeit J.M., Lu Z.H. Cancer Res. 70:8937-8947(2010) · Mapped (4) |
| Prognostic impact of ERbeta and MMP7 expression on overall survival in colon cancer. Fang Y.J., Lu Z.H., Wang F., Wu X.J., Li L.R., Zhang L.Y., Pan Z.Z., Wan D.S. Tumour Biol. 31:651-658(2010) · Mapped (4) |
| The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Zhao W.G., Yu S.N., Lu Z.H., Ma Y.H., Gu Y.M., Chen J. Carcinogenesis 31:1726-1733(2010) · Mapped (8) |
| Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis. Lu Z.H., Shvartsman M.B., Lee A.Y., Shao J.M., Murray M.M., Kladney R.D., Fan D., Krajewski S., Chiang G.G., Mills G.B. et al. Cancer Res. 70:3287-3298(2010) · Mapped (11) |
| [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance]. Ma Y.H., Wang K., Li L., Lu Z.H., Chen J. Zhonghua Bing Li Xue Za Zhi 39:5-9(2010) · Mapped (9) |
| [Relations between ALT level and count of HBV special CTL and non-specific CTL in patients with chronic hepatitis B]. Gu X.B., Yang X.J., Wang D., Hua Z., Wu H.Y., Xu Y.Q., Lu Z.H. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 23:343-345(2009) · Mapped (3) |
| T300A polymorphism of ATG16L1 and susceptibility to inflammatory bowel diseases: a meta-analysis. Cheng J.F., Ning Y.J., Zhang W., Lu Z.H., Lin L. World J. Gastroenterol. 16:1258-1266(2010) · Mapped (8) |
| MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells. Fang Y.J., Pan Z.Z., Li L.R., Lu Z.H., Zhang L.Y., Wan D.S. J. Exp. Clin. Cancer Res. 28:132-132(2009) · Mapped (4) |
| [Expression and clinical significance of survivin and matrix metalloproteinase-7 in colon cancer]. Wang G.Q., Lu Z.H., Fang Y.J., Chen G., Zhou Z.W., Pan Z.Z., Wan D.S. Ai Zheng 28:945-949(2009) · Mapped (13) |
| Correlation of the SNPs of FGFR1, FGF10, FGF18 with nonsyndromic cleft lip with or without palate in Chinese population. Wan W.D., Yang S.L., Liu J.Y., Cui Y.G., Zhou X.P., Guo F.F., Cheng H.Y., Cheng L., Xiao P.F., Lu Z.H. Beijing Da Xue Xue Bao 41:409-413(2009) · Mapped (4) |
| Sialidase occurs in both membranes of the nuclear envelope and hydrolyzes endogenous GD1a. Wang J., Wu G., Miyagi T., Lu Z.H., Ledeen R.W. J. Neurochem. 111:547-554(2009) · Mapped (11) |
| Sodium-calcium exchanger complexed with GM1 ganglioside in nuclear membrane transfers calcium from nucleoplasm to endoplasmic reticulum. Wu G., Xie X., Lu Z.H., Ledeen R.W. Proc. Natl. Acad. Sci. U.S.A. 106:10829-10834(2009) · Mapped (9) |
| Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Fang Y.J., Lu Z.H., Wang G.Q., Pan Z.Z., Zhou Z.W., Yun J.P., Zhang M.F., Wan D.S. Int J Colorectal Dis 24:875-884(2009) · Mapped (16) |
| Polymorphisms of the ribonucleotide reductase M1 gene and sensitivity to platin-based chemotherapy in non-small cell lung cancer. Feng J.F., Wu J.Z., Hu S.N., Gao C.M., Shi M.Q., Lu Z.H., Sun X.C., Zhou J.R., Chen B.A. Lung Cancer 66:344-349(2009) · Mapped (7) |